Foslevodopa is under investigation in clinical trial NCT04750226 (Study to Assess Adverse Events and Change in Disease Activity of 24-hour Continuous Subcutaneous Infusion of ABBV-951 in Adult Participants With Advanced Parkinson's Disease).
Fitur visualisasi ini dikembangkan menggunakan pendekatan Graph Theory untuk memetakan hubungan polifarmasi dan molekuler. Entitas (Obat, Target, Gen) direpresentasikan sebagai Simpul (Nodes), sedangkan hubungan biologisnya sebagai Sisi (Edges).
drugbank-id dan name pada skema XML DrugBank.targets/target yang memuat polipeptida sasaran.gene-name dan varian snp-effects.Tata letak grafik menggunakan algoritma Force-Directed Graph (Barnes-Hut). Model fisika ini menerapkan gaya tolak-menolak antar simpul (Gravitasi: -3000) agar tidak tumpang tindih, serta gaya pegas (Spring: 0.04) pada garis penghubung untuk fleksibilitas interaksi.
| Methylphenidate | The risk or severity of adverse effects can be increased when Methylphenidate is combined with Foslevodopa. |
| Dexmethylphenidate | The risk or severity of adverse effects can be increased when Dexmethylphenidate is combined with Foslevodopa. |
| Metoclopramide | The therapeutic efficacy of Foslevodopa can be decreased when used in combination with Metoclopramide. |
| Ziprasidone | The therapeutic efficacy of Foslevodopa can be decreased when used in combination with Ziprasidone. |
| Olanzapine | The therapeutic efficacy of Foslevodopa can be decreased when used in combination with Olanzapine. |
| Clozapine | The therapeutic efficacy of Foslevodopa can be decreased when used in combination with Clozapine. |
| Risperidone | The therapeutic efficacy of Foslevodopa can be decreased when used in combination with Risperidone. |
| Quetiapine | The therapeutic efficacy of Foslevodopa can be decreased when used in combination with Quetiapine. |
| Aripiprazole | The therapeutic efficacy of Foslevodopa can be decreased when used in combination with Aripiprazole. |
| Paliperidone | The therapeutic efficacy of Foslevodopa can be decreased when used in combination with Paliperidone. |
| Bifeprunox | The therapeutic efficacy of Foslevodopa can be decreased when used in combination with Bifeprunox. |
| Iloperidone | The therapeutic efficacy of Foslevodopa can be decreased when used in combination with Iloperidone. |
| Cariprazine | The therapeutic efficacy of Foslevodopa can be decreased when used in combination with Cariprazine. |
| Lumateperone | The therapeutic efficacy of Foslevodopa can be decreased when used in combination with Lumateperone. |
| Sertindole | The therapeutic efficacy of Foslevodopa can be decreased when used in combination with Sertindole. |
| Asenapine | The therapeutic efficacy of Foslevodopa can be decreased when used in combination with Asenapine. |
| Amisulpride | The therapeutic efficacy of Foslevodopa can be decreased when used in combination with Amisulpride. |
| Lurasidone | The therapeutic efficacy of Foslevodopa can be decreased when used in combination with Lurasidone. |
| Perospirone | The therapeutic efficacy of Foslevodopa can be decreased when used in combination with Perospirone. |
| Brexpiprazole | The therapeutic efficacy of Foslevodopa can be decreased when used in combination with Brexpiprazole. |
| Blonanserin | The therapeutic efficacy of Foslevodopa can be decreased when used in combination with Blonanserin. |
| Melperone | The therapeutic efficacy of Foslevodopa can be decreased when used in combination with Melperone. |
| Zotepine | The therapeutic efficacy of Foslevodopa can be decreased when used in combination with Zotepine. |
| Brilaroxazine | The therapeutic efficacy of Foslevodopa can be decreased when used in combination with Brilaroxazine. |
| Aripiprazole lauroxil | The therapeutic efficacy of Foslevodopa can be decreased when used in combination with Aripiprazole lauroxil. |
| Loxapine | The therapeutic efficacy of Foslevodopa can be decreased when used in combination with Loxapine. |
| Promazine | The therapeutic efficacy of Foslevodopa can be decreased when used in combination with Promazine. |
| Prochlorperazine | The therapeutic efficacy of Foslevodopa can be decreased when used in combination with Prochlorperazine. |
| Droperidol | The therapeutic efficacy of Foslevodopa can be decreased when used in combination with Droperidol. |
| Chlorpromazine | The therapeutic efficacy of Foslevodopa can be decreased when used in combination with Chlorpromazine. |
| Haloperidol | The therapeutic efficacy of Foslevodopa can be decreased when used in combination with Haloperidol. |
| Fluphenazine | The therapeutic efficacy of Foslevodopa can be decreased when used in combination with Fluphenazine. |
| Thioridazine | The therapeutic efficacy of Foslevodopa can be decreased when used in combination with Thioridazine. |
| Trifluoperazine | The therapeutic efficacy of Foslevodopa can be decreased when used in combination with Trifluoperazine. |
| Perphenazine | The therapeutic efficacy of Foslevodopa can be decreased when used in combination with Perphenazine. |
| Flupentixol | The therapeutic efficacy of Foslevodopa can be decreased when used in combination with Flupentixol. |
| Mesoridazine | The therapeutic efficacy of Foslevodopa can be decreased when used in combination with Mesoridazine. |
| Pimozide | The therapeutic efficacy of Foslevodopa can be decreased when used in combination with Pimozide. |
| Chlorprothixene | The therapeutic efficacy of Foslevodopa can be decreased when used in combination with Chlorprothixene. |
| Methotrimeprazine | The therapeutic efficacy of Foslevodopa can be decreased when used in combination with Methotrimeprazine. |
| Periciazine | The therapeutic efficacy of Foslevodopa can be decreased when used in combination with Periciazine. |
| Molindone | The therapeutic efficacy of Foslevodopa can be decreased when used in combination with Molindone. |
| Thioproperazine | The therapeutic efficacy of Foslevodopa can be decreased when used in combination with Thioproperazine. |
| Thiothixene | The therapeutic efficacy of Foslevodopa can be decreased when used in combination with Thiothixene. |
| Zuclopenthixol | The therapeutic efficacy of Foslevodopa can be decreased when used in combination with Zuclopenthixol. |
| Azaperone | The therapeutic efficacy of Foslevodopa can be decreased when used in combination with Azaperone. |
| Bupropion | The risk or severity of adverse effects can be increased when Bupropion is combined with Foslevodopa. |